Vitamin-C-megaskorbicka-liecba.pdf - Zdravie.sk

Vitamín C a megaskorbická liečba – zabudnutý poklad 381 / 436
Zdroje
[739] Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of
prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1978 Sep;75(9):4538-42.
PMID:279931. PMCID: PMC336151. http://www.pnas.org/content/75/9/4538.abstract?ck=nck
[740] Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer: prolongation of
survival times in terminal human cancer. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3685-9. PMID:1068480.
http://www.pnas.org/content/73/10/3685.full.pdf+html
[741] Hickey S, Roberts H. Cancer: Nutrition and Survival. Lulu Press, 2005. ISBN-10: 141166339X. ISBN-13:
978-1411663398.
[742] Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S. Failure of high-dose
vitamin C (ascorbic acid) to benefit patients with advanced cancer: a controlled trial. N Engl J Med. 1979 Sep
27;301(13):687-90. PMID:384241.
[743] Moertel CG, Fleming TR, Creagan ET, Rubin J, O'Connell MJ, Ames MM. High-dose vitamin C versus placebo
in the treatment of patients with advanced cancer who had had no prior chemotherapy. N Engl J Med. 1985
Jan 17;312(3):137-41. PMID:3880867.
[744] Robinson AR, Hunsberger A, Westall FC. Suppression of squamous cell carcinoma in hairless mice by
dietary nutrient variation. Mech Ageing Dev. 1994 Oct 20;76(2-3):201-14. PMID:7885065.
http://www.nutritionandcancer.org/view/nutritionandcancer/oism_nac.pdf
[745] Schlegel JU, Pipkin GE, Nishimura R, Shultz GN. The Role of Ascorbic Acid in the Prevention of Bladder
Tumor Formation. Trans Am Assoc Genitourin Surg. 1969;61:85-9. PMID:5351630.
[746] Lee SK, Kang JS, Jung da J, Hur DY, Kim JE, Hahm E, Bae S, Kim HW, Kim D, Cho BJ, Cho D, Shin DH,
Hwang YI, Lee WJ. Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the
inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II)
production. J Cell Physiol. 2008 Jul;216(1):180-8. PMID:18297687. DOI:10.1002/jcp.21391.
http://www3.interscience.wiley.com/journal/117919541/abstract
[747] Giraldo G, Beth E, Huang ES. Kaposi's sarcoma and its relationship to cytomegalovirus (CMNV). III. CMV
DNA and CMV early antigens in Kaposi's sarcoma. Int J Cancer. 1980 Jul 15;26(1):23-9. PMID:6263803.
[748] Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus
particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci
U S A. 1980 Dec;77(12):7415-9. PMID:6261256. PMCID: PMC350514.
[749] Mary E. Wilson, MD. SV40 Sequences Found in Non-Hodgkin's Lymphoma. Published in Journal Watch
Infectious Diseases April 11, 2002. Covering Lancet 2002 Mar 9.
[750] Vilchez RA, Butel JS. SV40 in human brain cancers and non-Hodgkin's lymphoma. Oncogene. 2003 Aug
11;22(33):5164-72. PMID:12910253. DOI:10.1038/sj.onc.1206547.
http://www.nature.com/onc/journal/v22/n33/full/1206547a.html
[751] Vilchez RA, Madden CR, Kozinetz CA, Halvorson SJ, White ZS, Jorgensen JL, Finch CJ, Butel JS. Association
between simian virus 40 and non-Hodgkin lymphoma. Lancet. 2002 Mar 9;359(9309):817-23.
PMID:11897278.
[752] Pauling L. Biostatistical analysis of mortality data for cohorts of cancer patients. Proc Natl Acad Sci U S A.
1989 May;86(10):3466-8. PMID:2726729. PMCID: PMC287158.
[753] Pauling L, Herman ZS. Criteria for the validity of clinical trials of treatments of cohorts of cancer patients
based on the Hardin Jones principle. Proc Natl Acad Sci U S A. 1989 Sep;86(18):6835-7. PMID:2780542.
PMCID: PMC297944.
[754] Hoffer A, Pauling L. Hardin Jones biostatistical analysis of mortality data for cohorts of cancer patients with
a large fraction surviving at the termination of the study and a comparison of survival times of cancer patients
receiving large regular oral doses of vitamin C and other nutrients with similar patients not receiving those
doses. J Orthomolecular Med. 1990;5:143-154. http://www.orthomolecular.org/library/jom/1990/pdf/1990-
v05n03-p143.pdf
Reprinted in, Cancer and Vitamin C, Updated and Expanded E Cameron and L Pauling, Camino Books, Inc. P.O.
Box 59026, Phil. PA, 19102, 1993.
[755] Hoffer A, Pauling L. Hardin Jones biostatistical analysis of mortality data for a second set of cohorts of
cancer patients with a large fraction surviving at the termination of the study and a comparison of survival
times of cancer patients receiving large regular oral doses of vitamin C and other nutrients with similar
patients not receiving these doses. J Orthomolecular Med. 1993;8:154-167
http://www.orthomolecular.org/library/jom/1993/pdf/1993-v08n03-p157.pdf
[756] Hoffer A. Orthomolecular Oncology. In, Adjuvant Nutrition in Cancer Treatment, Eds: P Quillin & RM
Williams. 1992 Symposium Proceedings, Sponsored by Cancer Treatment Research Foundation and American
College of Nutrition. Cancer Treatment Research Foundation, 3455 Salt Creek Lane, Suite 200, Arlington
Heights, IL 60005-1090, 331-362, 1994.
[757] Hoffer A. Orthomolecular Treatment of Cancer. In: Nutrients in Cancer Prevention and Treatment. Ed.
Kedar N. Prasad, Leonida Santamaria, R. Michael Williams. 1995. 395 pages, Humana Press, Totowa, New
Jersey. ISBN 089603318X, 9780896033184. Pages 373-39
[758] Hoffer A. One Patient's Recovery From Lymphoma. Townsend Letter for Doctors and Patients. 1996;160:50-
1. http://www.tldp.com/issue/160/160one.htm
[759] Abram Hoffer. Orthomolecular Medicine for Physicians. Keats Publising, New Canaan, CT, 1989. 247 pgs.
ISBN-10: 0879833904. ISBN-13: 978-0879833909.
[760]Hoffer A. How to live longer even with cancer. J Orthomol Med. 1996;11(3):147-67.
http://www.orthomolecular.org/library/jom/1996/pdf/1996-v11n03-p147.pdf
[761] Abram Hoffer and Andrew Saul. Orthomolecular Medicine for Everyone: Megavitamin Therapeutics
for Families and Physicians. Basic Health Publications, 2008. ISBN: 1591202264.